Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9
Express Pharma|December 2024
Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications
Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9

With a dispensing range of 0.05ml 10ml (50μl 10,000μl), the self refilling syringe comes with an individual calibration certificate and has a dosing accuracy tolerance of <0.4 per cent of the dose.

Blissfill is an automatic hand-operated self-refilling pipette syringe designed for continuous repetitive dispensing at the laboratory. The inert liquid path ensures that there is no component contamination to the liquid and comes with a calibration certificate. The syringe with the integrated valve system proves to be an excellent solution for accurate delivery of repetitive fixed doses without any errors during use. The comfortable grip and ergonomic design ensure fatigue free working during serial precision dosing. The fast and reliable volume selection ensures highly accurate dosing. The robust construction makes it easily autoclavable. The Luer lock nozzle is made as per universal specs and ensures fitment of any laboratory needle (reusable or disposable). The syringe comes with a one year warranty for manufacturing defects. The liquid path consist of borosilicate glass, SS 304, Ni-Cr plated brass, FPM, PTFE and silicone.

Features

◆ As per ISO 8655-9

◆ Autoclavable at 121°C for 20 minutes

Dosing accuracy: Tolerance <0.4 per cent of dose

◆ Silicone, borosilicate glass, FPM, stainless steel, nickel chrome plated brass

◆ No 'O' ring or lubrication needed during use

◆ Plunger tightness without O ring - hence no contamination when it comes in contact with drug/liquid. The smooth plunger travel and tightness is achieved through the high-precision stainless steel plunger and grounded glass barrel. No O-ring to mess with or replace ever

This story is from the December 2024 edition of Express Pharma.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the December 2024 edition of Express Pharma.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM EXPRESS PHARMAView All
CILICANT is changing the way we think about active packaging
Express Pharma

CILICANT is changing the way we think about active packaging

Team CILICANT shared insights into their journey of innovation, customer-centric solutions, and their ambitious plans for global expansion. In this engaging dialogue, the team also shed light on their unique value proposition, recent achievements, and strategies for adapting to a rapidly evolving pharma landscape, in an exclusive conversation with Express Pharma

time-read
4 mins  |
January 2025
KPMG 2024 Life Sciences CEO Outlook
Express Pharma

KPMG 2024 Life Sciences CEO Outlook

This recent KPMG report explores the perspectives and priorities of life sciences CEOs amid economic and geopolitical uncertainty, focusing on growth strategies, digital transformation, ESG goals, and workforce challenges. Excerpts from the report

time-read
7 mins  |
January 2025
Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends
Express Pharma

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Industry experts highlight the evolving dynamics, regulatory needs, and personalised solutions driving the nutra market ahead of 2025

time-read
4 mins  |
January 2025
We aim to strengthen our presence in Asian and MENA regions, with particular emphasis on India
Express Pharma

We aim to strengthen our presence in Asian and MENA regions, with particular emphasis on India

Matthias Poslovski, Chief Sales Officer, Optima Pharma, speaks on the company's evolution and shares insights on emerging trends like personalised medicine, digitalisation, and Al-driven technologies, while outlining his company's strategies for market expansion, particularly in Asia and MENA, with a focus on the Indian pharma sector, in an exclusive interaction with Lakshmipriya Nair

time-read
4 mins  |
January 2025
Sustaining excellence: The evolving role of quality in pharma
Express Pharma

Sustaining excellence: The evolving role of quality in pharma

In the ever-evolving landscape of the pharma industry, the pursuit of quality remains a cornerstone of success. As stringent regulatory frameworks, rising patient expectations, and the increasing pace of innovation, transforms the pharma industry, the definition of quality is also evolving. From ensuring compliance with global standards to embracing cutting-edge technologies like Al-driven quality control, the industry is navigating a paradigm shift in how it approaches product integrity, safety, and efficacy. In this New Year issue, pharma experts explore how crucial it is to foster a culture of quality across organisations and deliver better healthcare outcomes

time-read
5 mins  |
January 2025
Revolutionising pharma the adaptive way
Express Pharma

Revolutionising pharma the adaptive way

Adaptive manufacturing offers better performance, efficient management of diverse products, a reduced machine footprint, faster batch changes, and enhanced operational sustainability

time-read
3 mins  |
January 2025
Trends 2025: Redefining the pharma supply chain
Express Pharma

Trends 2025: Redefining the pharma supply chain

Saurabh Gupta, Global Head of Supply Chain, Lupin highlights trends such as Al integration, digitalisation and sustainability that are shaping a future-ready supply chain

time-read
4 mins  |
January 2025
Growth mantras for 2025: Innovation, Partnerships, Sustainability
Express Pharma

Growth mantras for 2025: Innovation, Partnerships, Sustainability

Innovation, synergy, and sustainability are shaping the trajectory of India's pharma sector, unlocking new frontiers of growth, inform industry stakeholders

time-read
2 mins  |
January 2025
Will Epygen's biosimilars bets pay off?
Express Pharma

Will Epygen's biosimilars bets pay off?

Debayan Ghosh, founder, Epygen Group, has ambitious plans to snag a slice of the booming $70 billion global biosimilar pie. In a conversation with Viveka Roychowdhury, he analyses the journey so far, spanning pandemic preparedness projects like protein-based vaccines, building up pipeline revenue streams in diabetes, oncology, immunology and cardiovascular biosimilars, and his strategies to scale up and expand to other therapeutics like anti-obesity drugs

time-read
9 mins  |
January 2025
Innovation, partnerships and best practices: Priorities for biopharma in 2025
Express Pharma

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth

time-read
3 mins  |
January 2025